News
Stay informed about all the news
and events we attend
Oxolife attend to ESHRE Congress 2022
These days the OXOLIFE team is in Milan (Italy) at European Society of Human Reproduction […]
At @OXOLIFE we are celebrating!
After 9 months of recruiting women who are looking for pregnancy, we have finally passed […]
Oxolife in the News
Our CEO Agnes Arbat is interviewed at IB radio to talk about our OXOART2 Clinical […]
Oxolife initiates a collaboration with the University of Cordoba and Rutgers, The State University of New Jersey, to develop a treatment to improve women’s fertility
The biotechnology company Oxolife S.L. (Spain), the Energy Balance, Puberty and Reproductive Health research group […]
ANOTHER BIG MILESTONE FOR OXOLIFE
We are delighted to announce that OXOART2, the OXO-001 phase II clinical trial, has already […]
Good feelings in the investigators meetings
On the 9th of September, we had the pleasure to meet the Czech and Polish […]
OXOART2 is here: First Investigators Meeting
Last Thursday 2nd of September, we had the pleasure to celebrate the first investigator meeting […]
UNPRECEDENTED APPROACH: Oxolife shows up in El Punt Avui
OXOLIFE is developing the first drug that will treat female infertility by improving the endometrium to […]
OXOLIFE presents the latest results in the ASRM21
Oxolife will present its newest evidences on OXO-001 in fertility and embryo implantation in the […]